基于协议的11.7%高压盐水输液的疗效和脏安全性,与20%曼尼托尔相比,在脑内血压升高的患者中:随机临床试验的研究方案
相关实验视频
Updated: Jun 3, 2025

07:15
Intranasal Administration of CNS Therapeutics to Awake Mice
Published on: April 8, 2013
58.8K
1Division of Nephrology, Department of Internal Medicine, Dankook University Hospital, Republic of Korea.
Electrolyte & blood pressure : E & BP
|January 9, 2025
概括
这项研究比较了高血压盐水 (HTS) 和曼尼托尔用于治疗高内压 (ICP),重点关注脏安全性和有效性. 结果将指导临床选择管理ICP和减少并发症.
科学领域:
- 神经外科和重症监护医学
- 药理学和治疗学 药理学和治疗学
背景情况:
- 内压升高 (ICP) 是一种需要立即治疗的危急状况.
- 曼尼托和高血压盐水 (HTS) 是常见的高透剂,可用于提高ICP,但对脏的安全性和疗效的比较数据有限.
研究的目的:
- 为了比较基于协议的11.7%HTS与20%曼尼托尔的安全性和疗效,在患有高ICP的患者中.
- 在临床实践中提供优化高透剂选择的证据.
主要方法:
- 一个单中心的实用随机试验,涉及116名重症监护病房患者,其ICP升高.
- 随机分配到11.7%的HTS (奇数月) 或20%的曼尼托尔 (偶数月).
- 血清电解质,度,功能和脑CT扫描的监测;临床和神经学评估.
主要成果:
- 主要结局包括急性损伤 (KDIGO标准),机械呼吸,肺,并在7天内保持液体.
- 其次性结局包括ICU/住院长度,30/90天死亡率和格拉斯哥昏迷量表得分.
- 假设:HTS将显示较低的急性损伤发病率与可比的ICP管理效率.
结论:
- 这项试验旨在确定关于HTS与曼尼托尔在高ICP时的比较疗效和安全性的最终证据.
- 预计这些发现将为临床指导方针提供信息,改善患者的治疗结果,并减少与治疗有关的并发症.
相关概念视频
Open Angle Glaucoma: Treatment
391
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
391
Tonicity in Animals
3.0K
Tonicity describes the amount of solute in a solution. The measure of the tonicity of a solution, or the total amount of solutes dissolved in a specific amount of solution, is called its osmolarity. Three terms—hypotonic, isotonic, and hypertonic—are used to relate the osmolarity of a cell to the osmolarity of the extracellular fluid that contains the cells. In a hypotonic solution, such as tap water, the extracellular fluid has a lower concentration of solutes than the fluid inside...
3.0K
Transcellular Transport of Solutes
3.4K
Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
3.4K
Formation of Concentrated Urine
1.5K
There is a gradient of solutes in the interstitial fluid from the renal cortex through the medulla, known as the medullary osmotic gradient. The juxtamedullary nephrons establish and maintain this gradient using countercurrent mechanisms with loops extending deep into the medulla. These nephrons also use countercurrent mechanisms to regulate urine volume and concentration. The interaction between the descending and ascending limbs of the nephron loop creates an osmotic gradient through...
1.5K
Formation of Dilute Urine
1.3K
The formation of dilute urine is a critical renal adaptation that maintains fluid balance, particularly during periods of high fluid intake. This process primarily involves the juxtamedullary nephrons. By adjusting the permeability of water and ions in response to physiological conditions, the kidneys can either conserve or excrete water, resulting in concentrated or dilute urine.
Filtrate Osmolarity in the PCT
Initially, as the filtrate passes through the proximal convoluted tubule (PCT), its...
Filtrate Osmolarity in the PCT
Initially, as the filtrate passes through the proximal convoluted tubule (PCT), its...
1.3K

